BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 12, 2004
View Archived Issues
Arpida Raises CHF51.3M, Plans To Move Iclaprim Into Phase III
Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. (BioWorld International)
Read More
Faust Pharmaceuticals Closes EUR16M Second-Round Financing
Read More
Molecular Switch That Triggers Apoptosis Delivers Drug Target
Read More
Eirx Out-Licenses Apoptosis Targets To OSI In $18.8M Deal
Read More
Lectus Gets Investment From Takeda For PFD Protein Work
Read More
Report: 25 Recommendations For EU Strategies On Genetic Testing
Read More
Immatics Raises EUR8.5M In First Round Of Financing
Read More
Advanced Biotherapy Cross-Licenses IP With Innogenetics
Read More
Biota Holdings Suing GSK Over Support For Flu Drug
Read More
Other News To Note
Read More